Digang, Ramilo D.
HRN: 17-58-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2024
MUPIROCIN 2%, 15G (TUBE)
06/12/2024
06/19/2024
TOPICAL
Apply Generously
BID
Abrasions Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes